EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...

The approval is based on the phase 3 MARIPOSA study, which showed that the combination therapy demonstrated superior overall survival compared to the current standard treatment, osimertinib ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

Six days after starting osimertinib treatment, the patient developed multiple patchy red rashes, initially concentrated on the anterior chest and then gradually extending to the abdomen and lower ...

Key opinion leaders examine approaches to managing skin-related side effects, such as rash, in patients on EGFR inhibitors, highlighting strategies to address quality-of-life impacts while maintaining ...

The drug Osimertinib (Tagrisso), developed by AstraZeneca, has been shown to double survival time in specific cases and will now be routinely available following a recommendation from the National ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from returning after surgery when taken with chemotherapy. It has been recommended by the National Institute for ...

According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific mutations. Osimertinib can help stop cancer from returning after surgery when ...

EGFR mutations, which are prevalent in cases of NSCLC, lead to abnormal cell growth, but Osimertinib works by targeting these mutated cells, aiming to prevent the cancer's return post-surgery.

In response, the body prioritizes central blood volume by reducing circulation to the skin, which can result in a purple-red rash appearing on the cheeks and the bridge of the nose. Shaped ...

Parents are heartbroken as a beloved nappy rash cream - Metanium Nappy Rash Ointment - is discontinued. The product, known for its quick healing properties, has been a staple in changing bags for ...